Key Findings
Global equivalent sales volume reached approximately 180 liters in 2025 and is estimated at about 220 liters in 2026
Average selling prices remain close to US$70,000 per liter due to low-volume and high-value bioprocess economics
Pan-serotype and multi-serotype products are gaining importance in platform-based AAV purification development
North America remains the largest demand center while China is expanding localized supply and second-source validation
Competition remains concentrated among a limited number of technically validated global and Chinese manufacturers
AAV Affinity Chromatography Resins Market Size(US$)

CAGR 2026-2032
13.3%
Market Size,2032
USD 32.06
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global AAV Affinity Chromatography Resins market was valued at US$ 13.06 million in 2025 and is anticipated to reach US$ 32.06 million by 2032, at a CAGR of 13.3% from 2026 to 2032.
AAV Affinity Chromatography Resins are high-value bioprocess chromatography media designed for the selective capture and primary purification of adeno-associated virus capsids during viral vector manufacturing. These products immobilize AAV-binding ligands, including single-domain antibodies, recombinant proteins, engineered protein scaffolds and synthetic peptides, onto cross-linked agarose or rigid polymer bead matrices. Commercial products are supplied mainly as loose bulk resins and prepacked columns, with validated formats ranging from milliliter-scale process-development packs to multi-liter manufacturing volumes. Key performance parameters include serotype coverage, dynamic binding capacity, pressure-flow behavior, recovery, impurity clearance, elution conditions, alkaline cleaning tolerance, ligand leakage and reusable cycle life. The market covers pan-serotype, limited multi-serotype and serotype-specific products used to capture AAV vectors produced through HEK293, Sf9 and other manufacturing platforms. Primary applications extend from resin screening and purification process development to clinical-stage GMP production, process validation, technology transfer, second-site qualification and commercial-scale viral vector manufacturing. As an upstream biopharmaceutical process material, AAV Affinity Chromatography Resins directly influence purification yield, process consistency, facility productivity, regulatory readiness and the overall economics of gene therapy manufacturing.
Market Trends
Market Segmentation
Market Dynamics
Drivers
Demand growth is primarily supported by the progression of AAV gene therapy programs from early clinical development into larger Phase II, Phase III and commercial manufacturing campaigns. Resin consumption per active project rises materially as processes move from screening and laboratory columns to engineering batches, validation campaigns and multi-site production. High-dose systemic therapies, expansion of viral vector CDMO capacity, qualification of backup manufacturing locations and increased use of platform purification processes further support resin demand. The requirement for higher recovery, consistent impurity removal and scalable GMP processing also encourages replacement of less selective purification approaches with dedicated AAV affinity capture steps.
Restraints
Market expansion is moderated by the small number of commercial AAV products, long development timelines and uncertainty surrounding the clinical success of individual gene therapy programs. AAV affinity resins are expensive to qualify and replace because changes to the capture step may require comparability studies, process revalidation and additional regulatory documentation. High resin prices encourage customers to optimize column loading and extend reusable cycle life, which reduces annual replacement volume. In addition, differences in feedstream quality, capsid design and production platforms can limit the transferability of performance data between projects, slowing adoption of newly launched products.
Opportunities
The strongest opportunities are emerging in affinity products for engineered capsids, broad platform resins, second-source qualification and localized GMP supply. As developers introduce novel capsids to improve tissue targeting, immune profiles and manufacturing yield, established binding ligands may lose affinity or require new process conditions. This creates demand for new ligand libraries, rapid resin screening services and product families that can move efficiently from development to commercial scale. Suppliers can also expand through integrated offerings combining loose resin, prepacked columns, process-development tools, ligand leakage assays, cleaning studies and regulatory support. China and other Asian markets offer additional opportunities as local gene therapy companies and CDMOs seek shorter lead times, lower procurement risk and alternatives to imported bioprocess materials.
Challenges
The market continues to face limited standardization in product-performance reporting. Suppliers use different units for binding capacity, including viral particles, vector genomes and capsid measurements, while residence time, feed composition and breakthrough definitions also vary. This makes direct comparison difficult and increases the burden of customer-side testing. Manufacturers must maintain consistent ligand production, coupling density, bead morphology, impurity control and lot-to-lot performance while scaling relatively small annual volumes. Commercial success also depends on building credible GMP documentation, extractables and leachables data, ligand leakage methods, cleaning validation and long-term supply commitments. Rapid changes in capsid engineering and the emergence of alternative capture formats may shorten product lifecycles and require continuous technology investment.
Industry Chain Analysis
The upstream segment of the AAV Affinity Chromatography Resins industry consists of agarose and synthetic polymer bead materials, functional monomers, cross-linking reagents, activation chemistries, spacer arms, affinity ligands and manufacturing-grade buffers. Ligand development is a particularly important source of differentiation because capsid selectivity, serotype coverage, elution behavior and alkaline stability depend strongly on ligand structure and immobilization chemistry. Matrix suppliers contribute particle-size control, pore architecture, mechanical strength and pressure-flow performance, while analytical materials and reference standards support binding, leakage and impurity testing.
The midstream segment integrates ligand discovery, matrix functionalization, coupling, washing, formulation, filling, quality control and batch release into a complete chromatography product. Value creation is concentrated in proprietary ligand technology, reproducible manufacturing, application data and regulatory support rather than in the base bead material alone. Downstream customers include gene therapy developers, biopharmaceutical companies, viral vector CDMOs, research institutions and manufacturing technology centers. These users evaluate products based on total process economics, including recovery, productivity, buffer consumption, resin lifetime, validation requirements and supply continuity. High small-pack prices support development-stage margins, while commercial contracts involve larger packaging discounts, technical service commitments and longer qualification cycles.
Segment Insights
By serotype coverage, pan-serotype and limited multi-serotype AAV affinity resins are becoming strategically important because they allow developers and CDMOs to standardize purification across multiple pipeline assets. These products are particularly valuable during early development, when capsid selection may change and a common capture platform can reduce process-development time. Serotype-specific resins remain relevant where higher selectivity, stronger binding or more favorable elution performance can be achieved for important capsids such as AAV8 and AAV9. Products with insufficiently disclosed serotype validation remain a smaller and less differentiated part of the market.
Cross-linked agarose represents the most widely used matrix route among current commercial products because of its established bioprocess acceptance and favorable hydrophilic characteristics. Rigid polystyrene divinylbenzene, polymethacrylate and polyvinyl ether matrices provide alternative pressure-flow and mass-transfer performance for higher-throughput processing. Single-domain antibody ligands are the most frequently represented affinity route in the current product landscape, while synthetic peptides, recombinant proteins and engineered protein scaffolds provide differentiated options in stability, selectivity and manufacturing control. Loose bulk resin accounts for most manufacturing-stage consumption, whereas prepacked columns and small-volume formats play a larger role in screening, process development and technology transfer.
Downstream Market Opportunities
Downstream opportunities are concentrated in process development, clinical manufacturing and commercial viral vector production. Development laboratories generate frequent but small-volume demand for serotype screening, capacity studies, cleaning evaluation and buffer optimization. Clinical-stage programs require larger quantities for engineering batches, GMP campaigns and process transfer, while late-stage and commercial projects create the highest resin demand per active program through validation, multiple production sites and planned replacement inventories. Both HEK293 and Sf9-based AAV manufacturing platforms require selective capture solutions, although differences in host-cell impurities, feed concentration and lysis conditions create distinct performance requirements. Suppliers that can demonstrate consistent results across production platforms and engineered capsids are positioned to access a broader downstream customer base.
Regional Insights

Fastest-Growing Region: Asia Pacific
North America is the largest market for AAV Affinity Chromatography Resins, supported by its concentration of gene therapy developers, clinical programs, commercial products, specialized CDMOs and established bioprocess suppliers. Demand is characterized by strong regulatory-documentation requirements, high adoption of platform processes and significant use of prepacked development and manufacturing columns. Europe remains an important market through its advanced gene therapy research base, regulated manufacturing infrastructure and expertise in ligand and chromatography technology. European customers place particular emphasis on process robustness, supply assurance and lifecycle documentation.
By Type,2021-2032(US$ Million)
Pan-Serotype AAV Affinity Resins
Limited Multi-Serotype AAV Affinity Resins
Serotype-Specific AAV Affinity Resins
Other
By Application,2021-2032(US$ Million)
HEK293-Derived AAV Purification
Sf9-Derived AAV Purification
Other
China is developing into the most important emerging supply and demand center. Domestic companies have introduced pan-serotype, multi-serotype and serotype-specific products, while local gene therapy developers increasingly assess domestic materials as primary or backup sources. The competitive advantage of Chinese suppliers is centered on local technical support, shorter lead times, flexible packaging and pricing, although broader commercial GMP references and long-term cycle data remain important qualification requirements. Japan, South Korea, India, China Taiwan and Southeast Asia currently function mainly as development, manufacturing-service, distribution or regional technical-support markets, with a limited number of independent commercial AAV affinity resin producers.
Competitive Landscape Analysis
The competitive landscape is concentrated but gradually broadening. Established multinational suppliers benefit from installed customer processes, extensive application data, global distribution, regulatory support and demonstrated batch consistency. Their products are frequently embedded in clinical and commercial manufacturing processes, creating high switching costs and long customer retention. Specialized affinity technology companies compete through novel peptide ligands, engineered scaffolds, broad serotype coverage, mild elution and improved cleaning stability. Chinese manufacturers are expanding the market through locally developed ligands, agarose and polymer matrix capabilities, broader packaging flexibility and lower regional supply risk. However, competition is determined by more than nominal product price or binding capacity. Customers assess recovery, impurity clearance, capsid compatibility, pressure-flow behavior, reuse performance, ligand leakage, lot consistency and the supplier’s ability to support regulatory filings. The market is therefore expected to remain technically selective, with successful suppliers requiring both proprietary product performance and credible long-term manufacturing support.
Report Scope
This report delivers a comprehensive overview of the global AAV Affinity Chromatography Resins market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AAV Affinity Chromatography Resins. The AAV Affinity Chromatography Resins market size, estimates, and forecasts are provided in terms of sales volume (L) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global AAV Affinity Chromatography Resins market comprehensively. Regional market sizes by Type, by Application, by Matrix Material, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist AAV Affinity Chromatography Resins manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Matrix Material, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for AAV Affinity Chromatography Resins manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines AAV Affinity Chromatography Resins sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 AAV Affinity Chromatography Resins Market Overview
1.1 Product Definition
1.2 AAV Affinity Chromatography Resins by Type
1.2.1 Global AAV Affinity Chromatography Resins Market Value by Type: 2025 vs 2032
1.2.2 Pan-Serotype AAV Affinity Resins
1.2.3 Limited Multi-Serotype AAV Affinity Resins
1.2.4 Serotype-Specific AAV Affinity Resins
1.2.5 Other
1.3 AAV Affinity Chromatography Resins by Matrix Material
1.3.1 Global AAV Affinity Chromatography Resins Market Value by Matrix Material: 2025 vs 2032
1.3.2 Cross-Linked Agarose Resins
1.3.3 Cross-Linked Polystyrene Divinylbenzene Resins
1.3.4 Polymethacrylate Resins
1.3.5 Polyvinyl Ether Resins
1.3.6 Other
1.4 AAV Affinity Chromatography Resins by Application
1.4.1 Global AAV Affinity Chromatography Resins Market Value by Application: 2025 vs 2032
1.4.2 HEK293-Derived AAV Purification
1.4.3 Sf9-Derived AAV Purification
1.4.4 Other
1.5 Global AAV Affinity Chromatography Resins Market Size Estimates and Forecasts
1.5.1 Global AAV Affinity Chromatography Resins Revenue 2021–2032
1.5.2 Global AAV Affinity Chromatography Resins Sales 2021–2032
1.5.3 Global AAV Affinity Chromatography Resins Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 AAV Affinity Chromatography Resins Market Competition by Manufacturers
2.1 Global AAV Affinity Chromatography Resins Sales Market Share by Manufacturers (2021–2026)
2.2 Global AAV Affinity Chromatography Resins Revenue Market Share by Manufacturers (2021–2026)
2.3 Global AAV Affinity Chromatography Resins Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of AAV Affinity Chromatography Resins, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of AAV Affinity Chromatography Resins, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of AAV Affinity Chromatography Resins, Product Types and Applications
2.7 Global Key Manufacturers of AAV Affinity Chromatography Resins, Date of Entry into the Industry
2.8 Global AAV Affinity Chromatography Resins Market Competitive Situation and Trends
2.8.1 Global AAV Affinity Chromatography Resins Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global AAV Affinity Chromatography Resins Players Market Share by Revenue
2.8.3 Global AAV Affinity Chromatography Resins Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global AAV Affinity Chromatography Resins Market Scenario by Region
3.1 Global AAV Affinity Chromatography Resins Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global AAV Affinity Chromatography Resins Sales by Region: 2021–2032
3.2.1 Global AAV Affinity Chromatography Resins Sales by Region: 2021–2026
3.2.2 Global AAV Affinity Chromatography Resins Sales by Region: 2027–2032
3.3 Global AAV Affinity Chromatography Resins Revenue by Region: 2021–2032
3.3.1 Global AAV Affinity Chromatography Resins Revenue by Region: 2021–2026
3.3.2 Global AAV Affinity Chromatography Resins Revenue by Region: 2027–2032
3.4 North America AAV Affinity Chromatography Resins Market Facts & Figures by Country
3.4.1 North America AAV Affinity Chromatography Resins Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America AAV Affinity Chromatography Resins Sales by Country (2021–2032)
3.4.3 North America AAV Affinity Chromatography Resins Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe AAV Affinity Chromatography Resins Market Facts & Figures by Country
3.5.1 Europe AAV Affinity Chromatography Resins Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe AAV Affinity Chromatography Resins Sales by Country (2021–2032)
3.5.3 Europe AAV Affinity Chromatography Resins Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific AAV Affinity Chromatography Resins Market Facts & Figures by Region
3.6.1 Asia Pacific AAV Affinity Chromatography Resins Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific AAV Affinity Chromatography Resins Sales by Region (2021–2032)
3.6.3 Asia Pacific AAV Affinity Chromatography Resins Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America AAV Affinity Chromatography Resins Market Facts & Figures by Country
3.7.1 Latin America AAV Affinity Chromatography Resins Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America AAV Affinity Chromatography Resins Sales by Country (2021–2032)
3.7.3 Latin America AAV Affinity Chromatography Resins Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa AAV Affinity Chromatography Resins Market Facts & Figures by Country
3.8.1 Middle East and Africa AAV Affinity Chromatography Resins Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa AAV Affinity Chromatography Resins Sales by Country (2021–2032)
3.8.3 Middle East and Africa AAV Affinity Chromatography Resins Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global AAV Affinity Chromatography Resins Sales by Type (2021–2032)
4.1.1 Global AAV Affinity Chromatography Resins Sales by Type (2021–2026)
4.1.2 Global AAV Affinity Chromatography Resins Sales by Type (2027–2032)
4.1.3 Global AAV Affinity Chromatography Resins Sales Market Share by Type (2021–2032)
4.2 Global AAV Affinity Chromatography Resins Revenue by Type (2021–2032)
4.2.1 Global AAV Affinity Chromatography Resins Revenue by Type (2021–2026)
4.2.2 Global AAV Affinity Chromatography Resins Revenue by Type (2027–2032)
4.2.3 Global AAV Affinity Chromatography Resins Revenue Market Share by Type (2021–2032)
4.3 Global AAV Affinity Chromatography Resins Price by Type (2021–2032)
5 Segment by Application
5.1 Global AAV Affinity Chromatography Resins Sales by Application (2021–2032)
5.1.1 Global AAV Affinity Chromatography Resins Sales by Application (2021–2026)
5.1.2 Global AAV Affinity Chromatography Resins Sales by Application (2027–2032)
5.1.3 Global AAV Affinity Chromatography Resins Sales Market Share by Application (2021–2032)
5.2 Global AAV Affinity Chromatography Resins Revenue by Application (2021–2032)
5.2.1 Global AAV Affinity Chromatography Resins Revenue by Application (2021–2026)
5.2.2 Global AAV Affinity Chromatography Resins Revenue by Application (2027–2032)
5.2.3 Global AAV Affinity Chromatography Resins Revenue Market Share by Application (2021–2032)
5.3 Global AAV Affinity Chromatography Resins Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific Inc.
6.1.1 Thermo Fisher Scientific Inc. Company Information
6.1.2 Thermo Fisher Scientific Inc. Description and Business Overview
6.1.3 Thermo Fisher Scientific Inc. AAV Affinity Chromatography Resins Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Thermo Fisher Scientific Inc. AAV Affinity Chromatography Resins Product Portfolio
6.1.5 Thermo Fisher Scientific Inc. Recent Developments/Updates
6.2 Danaher Corporation
6.2.1 Danaher Corporation Company Information
6.2.2 Danaher Corporation Description and Business Overview
6.2.3 Danaher Corporation AAV Affinity Chromatography Resins Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Danaher Corporation AAV Affinity Chromatography Resins Product Portfolio
6.2.5 Danaher Corporation Recent Developments/Updates
6.3 Repligen Corporation
6.3.1 Repligen Corporation Company Information
6.3.2 Repligen Corporation Description and Business Overview
6.3.3 Repligen Corporation AAV Affinity Chromatography Resins Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Repligen Corporation AAV Affinity Chromatography Resins Product Portfolio
6.3.5 Repligen Corporation Recent Developments/Updates
6.4 Merck KGaA
6.4.1 Merck KGaA Company Information
6.4.2 Merck KGaA Description and Business Overview
6.4.3 Merck KGaA AAV Affinity Chromatography Resins Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Merck KGaA AAV Affinity Chromatography Resins Product Portfolio
6.4.5 Merck KGaA Recent Developments/Updates
6.5 ChromaGenix LLC
6.5.1 ChromaGenix LLC Company Information
6.5.2 ChromaGenix LLC Description and Business Overview
6.5.3 ChromaGenix LLC AAV Affinity Chromatography Resins Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 ChromaGenix LLC AAV Affinity Chromatography Resins Product Portfolio
6.5.5 ChromaGenix LLC Recent Developments/Updates
6.6 Shanghai Duoning Biotechnology Co., Ltd.
6.6.1 Shanghai Duoning Biotechnology Co., Ltd. Company Information
6.6.2 Shanghai Duoning Biotechnology Co., Ltd. Description and Business Overview
6.6.3 Shanghai Duoning Biotechnology Co., Ltd. AAV Affinity Chromatography Resins Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Shanghai Duoning Biotechnology Co., Ltd. AAV Affinity Chromatography Resins Product Portfolio
6.6.5 Shanghai Duoning Biotechnology Co., Ltd. Recent Developments/Updates
6.7 Changzhou Smart-Lifesciences Biotechnology Co., Ltd.
6.7.1 Changzhou Smart-Lifesciences Biotechnology Co., Ltd. Company Information
6.7.2 Changzhou Smart-Lifesciences Biotechnology Co., Ltd. Description and Business Overview
6.7.3 Changzhou Smart-Lifesciences Biotechnology Co., Ltd. AAV Affinity Chromatography Resins Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Changzhou Smart-Lifesciences Biotechnology Co., Ltd. AAV Affinity Chromatography Resins Product Portfolio
6.7.5 Changzhou Smart-Lifesciences Biotechnology Co., Ltd. Recent Developments/Updates
6.8 Shanghai Yaonuo Biotechnology Co., Ltd.
6.8.1 Shanghai Yaonuo Biotechnology Co., Ltd. Company Information
6.8.2 Shanghai Yaonuo Biotechnology Co., Ltd. Description and Business Overview
6.8.3 Shanghai Yaonuo Biotechnology Co., Ltd. AAV Affinity Chromatography Resins Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Shanghai Yaonuo Biotechnology Co., Ltd. AAV Affinity Chromatography Resins Product Portfolio
6.8.5 Shanghai Yaonuo Biotechnology Co., Ltd. Recent Developments/Updates
6.9 Kangyuan Medical Technology Dalian Co., Ltd.
6.9.1 Kangyuan Medical Technology Dalian Co., Ltd. Company Information
6.9.2 Kangyuan Medical Technology Dalian Co., Ltd. Description and Business Overview
6.9.3 Kangyuan Medical Technology Dalian Co., Ltd. AAV Affinity Chromatography Resins Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Kangyuan Medical Technology Dalian Co., Ltd. AAV Affinity Chromatography Resins Product Portfolio
6.9.5 Kangyuan Medical Technology Dalian Co., Ltd. Recent Developments/Updates
6.10 Shangchun Biotechnology Wuhan Co., Ltd.
6.10.1 Shangchun Biotechnology Wuhan Co., Ltd. Company Information
6.10.2 Shangchun Biotechnology Wuhan Co., Ltd. Description and Business Overview
6.10.3 Shangchun Biotechnology Wuhan Co., Ltd. AAV Affinity Chromatography Resins Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Shangchun Biotechnology Wuhan Co., Ltd. AAV Affinity Chromatography Resins Product Portfolio
6.10.5 Shangchun Biotechnology Wuhan Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 AAV Affinity Chromatography Resins Industry Chain Analysis
7.2 AAV Affinity Chromatography Resins Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 AAV Affinity Chromatography Resins Production Mode & Process Analysis
7.4 AAV Affinity Chromatography Resins Sales and Marketing
7.4.1 AAV Affinity Chromatography Resins Sales Channels
7.4.2 AAV Affinity Chromatography Resins Distributors
7.5 AAV Affinity Chromatography Resins Customer Analysis
8 AAV Affinity Chromatography Resins Market Dynamics
8.1 AAV Affinity Chromatography Resins Industry Trends
8.2 AAV Affinity Chromatography Resins Market Drivers
8.3 AAV Affinity Chromatography Resins Market Challenges
8.4 AAV Affinity Chromatography Resins Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Table of Figures
List of Tables
List of Figures
Related Reports
The global AAV Affinity Chromatography Resins market size was US$ 13.06 million in 2025 and is forecast to reach a readjusted size of US$ 32.06 million by 2032 with a CAGR of 13.3% during the forecast period 2026-2032.
Published Date: 2026-07-31
Pages: 130
USD 4250.00
(Single User License)
The global AAV Affinity Chromatography Resins market is projected to grow from US$ 13.06 million in 2025 to US$ 32.06 million by 2032, at a CAGR of 13.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-31
Pages: 137
USD 4900.00
(Single User License)
The global market for AAV Affinity Chromatography Resins was estimated to be worth US$ 13.06 million in 2025 and is projected to reach US$ 32.06 million, growing at a CAGR of 13.3% from 2026 to 2032.
Published Date: 2026-07-31
Pages: 127
USD 3950.00
(Single User License)
The global AAV Affinity Chromatography Resins market size was US$ 13.06 million in 2025 and is forecast to reach a readjusted size of US$ 32.06 million by 2032 with a CAGR of 13.3% during the forecast period 2026-2032.
Published: 2026-07-31
Pages: 130
The global AAV Affinity Chromatography Resins market is projected to grow from US$ 13.06 million in 2025 to US$ 32.06 million by 2032, at a CAGR of 13.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-31
Pages: 137
The global market for AAV Affinity Chromatography Resins was estimated to be worth US$ 13.06 million in 2025 and is projected to reach US$ 32.06 million, growing at a CAGR of 13.3% from 2026 to 2032.
Published: 2026-07-31
Pages: 127
REPORT COVERAGE
Key Findings
Market Trends
Market Segmentation
Market Dynamics
Industry Chain Analysis
Segment Insights
Downstream Market Opportunities
Regional Insights
Competitive Landscape Analysis
Report Scope
Chapter Outline
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research